May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

Ibex was selected among the first ever winners of the AI in Health and Care Award, sharing £50 million to enable a study of Ibex’s AI technology across multiple NHS trusts Tel Aviv, Israel - September 22, 2020 - Ibex Medical Analytics,...

The Proxima® spatial analysis software solution seamlessly integrates image acquisition to data analysis in the secure cloud for rapid access by any user. MENLO PARK, Calif.  — Akoya Biosciences, Inc., The Spatial Biology Company™,...

By combining Deciphex’s unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI PITTSBURGH and DUBLIN –  Cernostics, a privately-held...

MEDIA RELEASE First commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single sample As COVID-19 and influenza infections can hardly...

CorePlus completes deployment of Ibex Medical Analytics' Galen™ Prostate solution to support pathologists in accurate diagnosis, enhanced lab efficiency and quality control CAROLINA, Puerto Rico, Sept. 1, 2020 /PRNewswire/ -- CorePlus...

MEDIA RELEASE Detects, confirms and differentiates HIV-1 and HIV-2 infections providing clinicians with critical diagnostic data for personalised management of patients with HIV — from appropriate counseling on disease differences to...

OR

platinum partners

gold partners

Silver Partners

Media Partners